Furthermore, we demonstrated that the community cohesion scores successfully identified breast cancer subtypes (e.g. HR+ breast cancer and TNBC) and the subtype-specific therapeutic targets (e.g. ESR1 in the HR+ breast cancer) by exploring relatively decreased community cohesion scores in each subtype. This evidence concerns the gene ESR1 and breast cancer.